|
|
||||||||
US Department of Agriculture, Beltsville, MD 20705
Abstract
Twenty cyclic gilts were injected im with either saline (control) or 1,000 IU of human chorionic gonadotropin (hCG) on d 12 of the estrous cycle to determine the effects of hCG on follicular development and steroidogenesis. Blood was collected when gilts were sacrificed on d 13 or 16. Follicles were classified as medium (3 to 6 mm in diameter) or large (=6 mm diameter), dissected from the ovary, measured and weighed. Pieces of follicle wall were incubated 3 h in Krebs Ringer bicarbonate buffer (KRB) on ice in an atmosphere of air or at 37 C in an atmosphere of 95% O2:5% CO2. Unconjugated estrogen and progesterone in blood plasma, follicular fluid and 10,000 x g supernatants of incubated follicular tissue homogenates were quantified by radioimmuno-assay. On d 13 follicles on ovaries of control or hCG-injected gilts were <6 mm in diameter. On d 16, one of five control gilts had some large follicles, while all five hCG-treated gilts had large as well as medium follicles. On d 16 follicular fluid of large follicles from hCG-injected gilts contained twofold more estrogen and 40-fold more progesterone than medium follicles on the same ovaries. Tissue from large follicles of hCG-injected gilts produced more progesterone in vitro than did tissue from medium follicles (P<.05), but estrogen production did not differ. On d 16 medium follicles from control or hCG-injected gilts were larger, contained more estrogen and less progesterone than those recovered on d 13 (P<.01). However, medium follicles on d 13 and 16 from hCG-injected gilts were larger and their fluid contained more estrogen and progesterone than medium follicles from control gilts (P<.01). This study demonstrated that 1,000 IU of hCG injected on d 12 of the estrous cycle in the gilt resulted in development of large follicles, resembling preovulatory follicles at the onset of estrus before the preovulatory luteinizing hormone surge.
1 Reprod. Lab., Anim. Sci. Institute, Beltsville Agr. Res. Center, ARS.
2 Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee or warranty by the USDA and does not imply its approval to the exclusion of other products that may be suitable.
3 Current address: Good Samaritan Hospital, Lochraven Building, Baltimore, MD.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |